Jump to ContentJump to Main Navigation
Comprehensive Handbook of Childhood Cancer and Sickle Cell DiseaseA Biopsychosocial Approach$
Users without a subscription are not able to see the full content.

Ronald T. Brown

Print publication date: 2006

Print ISBN-13: 9780195169850

Published to Oxford Scholarship Online: November 2020

DOI: 10.1093/oso/9780195169850.001.0001

Show Summary Details
Page of

PRINTED FROM OXFORD SCHOLARSHIP ONLINE (oxford.universitypressscholarship.com). (c) Copyright Oxford University Press, 2021. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in OSO for personal use. date: 14 June 2021

Why a Comprehensive Handbook on Pediatric Psychosocial Oncology/Hematology

Why a Comprehensive Handbook on Pediatric Psychosocial Oncology/Hematology

Chapter:
(p.3) 1 Why a Comprehensive Handbook on Pediatric Psychosocial Oncology/Hematology
Source:
Comprehensive Handbook of Childhood Cancer and Sickle Cell Disease
Author(s):

Ronald T. Brown

Publisher:
Oxford University Press
DOI:10.1093/oso/9780195169850.003.0005

Over the past 25 to 30 years, monumental strides in national policy have been made in the management, treatment, and prevention of cancer. Rowland (2005) summarized these accomplishments, including legislation that provides for revenues and resources for research in cancer prevention and control. In addition, other pertinent policy issues have emerged from the Institute of Medicine, the National Cancer Institute, the Centers for Disease Control and Prevention, and the Lance Armstrong Foundation, all of which have served to increase the awareness of cancer, prevent the occurrence of cancer, and address cancer survivorship. Cancer policy issues have been models for increased resources and revenues for patient care, research, and quality-of-life enhancement. Nowhere is the success that we have had with policy more evident than in pediatric psychosocial oncology. The enormous advances in the prevention, medical treatment, medical management of late effects, and quality-of-life issues in children and adolescents surviving cancer have spawned a host of research in pediatric psychosocial oncology. These investigations likely surpass most research efforts for other chronic diseases. In fact, Bearison and Mulhern (1994) observed that there are more studies related to psychosocial oncology than perhaps there have been children with the disease. In my role as editor of the Journal of Pediatric Psychology, I conducted an informal survey of manuscripts; it indicated we process more submissions related to cancer than any other disease or chronic illness. Bearison and Mulhern also noted that psychological studies in the area of pediatric oncology have permeated most psychology and pediatric journals. Even the most dedicated scholar in psychosocial oncology and hematology has a difficult time keeping up with the everburgeoning literature body. Bearison and Mulhern published the last handbook on psychosocial issues in pediatric hematology/oncology in 1994. Since then, a proliferation of literature in the field has been concomitant with major developments in pediatric oncology, including increased use of chemotherapy, the evolution of bone marrow transplantation as a means of treating children and adolescents who have been refractory to chemotherapy and radiation therapy, and intensive investigation of survivorship and the late effects that many of these children endure.

Keywords:   bone tumors, cancer diagnosis, end-of-life decisions, funding for training, leukemia, neuroblastoma, palliative care, radiation therapy (RT), surgery

Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .